LPA3 Receptor Phosphorylation Sites: Roles in Signaling and Internalization
International Journal of Molecular Sciences · 2024
DOI: 10.3390/ijms25105508 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von K Helivier Solís und 3 weiteren Autor:innen. Beteiligte Einrichtung: Departamento de Biología Celular y Desarrollo, Instituto de Fisiología Celular, Universidad Nacional Autónoma de México, Ciudad Universitaria, Ap. Po…. Hauptthemen laut MEDLINE: Receptors, Lysophosphatidic Acid, Lysophospholipids, Signal Transduction. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Consejo Nacional de Humanidades, Ciencias y Tecnologías, Dirección General de Asuntos del Personal Académico- PAPIIT, CONAHCYT.
Abstract (Originalsprache)
Lysophosphatidic acid (LPA) type 3 (LPA3) receptor mutants were generated in which the sites detected phosphorylated were substituted by non-phosphorylatable amino acids. Substitutions were made in the intracellular loop 3 (IL3 mutant), the carboxyl terminus (Ctail), and both domains (IL3/Ctail). The wild-type (WT) receptor and the mutants were expressed in T-REx HEK293 cells, and the consequences of the substitutions were analyzed employing different functional parameters. Agonist- and LPA-mediated receptor phosphorylation was diminished in the IL3 and Ctail mutants and essentially abolished in the IL3/Ctail mutant, confirming that the main phosphorylation sites are present in both domains and their role in receptor phosphorylation eliminated by substitution and distributed in both domains. The WT and mutant receptors increased intracellular calcium and ERK 1/2 phosphorylation in response to LPA and PMA. The agonist, Ki16425, diminished baseline intracellular calcium, which suggests some receptor endogenous activity. Similarly, baseline ERK1/2 phosphorylation was diminished by Ki16425. An increase in baseline ERK phosphorylation was detected in the IL3/Ctail mutant. LPA and PMA-induced receptor interaction with β-arrestin 2 and LPA3 internalization were severely diminished in cells expressing the mutants. Mutant-expressing cells also exhibit increased baseline proliferation and response to different stimuli, which were inhibited by the antagonist Ki16425, suggesting a role of LPA receptors in this process. Migration in response to different attractants was markedly increased in the Ctail mutant, which the Ki16425 antagonist also attenuated. Our data experimentally show that receptor phosphorylation in the distinct domains is relevant for LPA3 receptor function
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Departamento de Biología Celular y Desarrollo, Instituto de Fisiología Celular, Universidad Nacional Autónoma de México, Ciudad Universitaria, Ap. Postal 70-600, Ciudad de México 04510, Mexico.
- Unidad de Imagenología, Instituto de Fisiología Celular, Universidad Nacional Autónoma de México, Ciudad Universitaria, Ap. Postal 70-600, Ciudad de México 04510, Mexico.
ORCID-Profile: K Helivier Solís, J Adolfo García-Sáinz
Förderung
- Consejo Nacional de Humanidades, Ciencias y Tecnologías
- Dirección General de Asuntos del Personal Académico- PAPIIT
- CONAHCYT
- DGAPA
Zitieren
APA
Solís, K. H., Romero-Ávila, M. T., Rincón-Heredia, R., & García-Sáinz, J. A. (2024). LPA3 Receptor Phosphorylation Sites: Roles in Signaling and Internalization. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25105508
Vancouver
Solís KH, Romero-Ávila MT, Rincón-Heredia R, García-Sáinz JA. LPA3 Receptor Phosphorylation Sites: Roles in Signaling and Internalization. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms25105508
BibTeX
@article{Sols2024,
author = {Solís, K Helivier and Romero-Ávila, M Teresa and Rincón-Heredia, Ruth and García-Sáinz, J Adolfo},
title = {LPA3 Receptor Phosphorylation Sites: Roles in Signaling and Internalization},
journal = {International Journal of Molecular Sciences},
year = {2024},
doi = {10.3390/ijms25105508}
}
EUVIMED